Latest Posts

Survey on Research Goals and Priorities for Lobular

You are invited to participate in a survey focused on Invasive Lobular Breast Cancer (ILC)  which was developed by an international group of researchers, clinicians and breast cancer advocates. The survey was approved by the University of Pittsburgh IRB.…

Keep reading

The Lobmob Effect

Leigh Pate founded The LBCA – Lobular Breast Cancer Alliance along with Professor Steffi Oesterrich, Lori Petitti, Diane Mapes #Lobmob It’s a real success story for Lobular Breast Cancer and an extraordinary example of what a group…

Keep reading

Lobular Translation across Europe

When I was Diagnosed with Lobular Breast Cancer, 6 years ago there was NO Lobular Specific information available to patients. That is now changed, Lobular Ireland and I are so proud to be a very small part…

Keep reading

Lobular Up Front

FOCUS ON LOBULAR BREAST CANCER Front Cover News thanks to Collaborative Research from The European Lobular Breast Cancer Consortium http://www.elbcc.org Congratulations from #ILC Patient Community Invasive lobular carcinoma (ILC) is the most common ‘‘special type’’ breast cancer…

Keep reading

Global Collaboration around Lobular Breast Cancer

Access to full article ✅ HERE How Researchers, Clinicians and Patient Advocates Can Accelerate Lobular Breast Cancer Research Lobular Ireland and founder Siobhán Freeney are extremely honoured to be named co author on this Paper and will…

Keep reading

Lobular Breast Cancer – what is it?

Breast Cancers are not all the same! Invasive Lobular Breast Cancer is the 2nd most common type of Breast Cancer and it is 6th most common type of Cancer in women overall. It is not often spoken…

Keep reading

Lobular Ireland

Another huge milestone for Lobular Ireland and European Lobular Breast Cancer Research and Advocacy Kudos to the Lead Authors for their personal time and commitment to getting this paper published. It’s an real honour to have our…

Keep reading

Exciting NEWS!

ELBCC (European Lobular Breast Cancer Consortium) have been working away in the background with patent advocates and experts to put together an informative and timely Patient Information Leaflet on all things Lobular. It’s a nifty few pages…

Keep reading

LOBSTERPOT aims to better understand, diagnose & treat ILC

Ireland is among the 21 countries in the LOBSTERPOT in this exciting development to improve treatment and outcomes for patients diagnosed with ILC, and importantly acknowledgement that ILC needs specific treatment. European Lobular Breast Cancer Consortium (ELBCC) with…

Keep reading

Loading…

Something went wrong. Please refresh the page and/or try again.

%d bloggers like this: